Intercept Reports Phase III Sub-Study Liver Biopsy Data
Intercept (ICPT) announces data from the POISE biopsy sub-study which showed that treatment with obeticholic acid leads to the reversal or stabilization of fibrosis/cirrhosis in patien.....»»
Vaccinex Reports Second Quarter 2019 Financial Results and Provides Corporate Update
Completed enrollment of the dose expansion cohort in the Phase 1b/2 CLASSICAL-Lung study in non-small cell lung cancer; primary completion expected in the second half of 2019 Presented interim data from CLASSICAL-Lung study.....»»
Deciphera reports updated data from Phase 1 ripretinib study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aptevo Therapeutics Reports Second Quarter 2019 Financial Results
Reports Positive Preliminary Top-Line Safety Data for APVO210Phase 1 Single Ascending Dose (SAD) Clinical Study Advances APVO210 into Phase 1 Multiple Ascending Dose (MAD) Study Co.....»»
Applied Therapeutics reports AT-007 SAD data from Phase 1/2 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Hemispherx reports "positive" data in Phase 1 study using Ampligen
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Evofem reports additional data from Phase 3 "AMPOWER" study of Amphora
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Entera Bio Reports First Quarter 2019 Financial Results and Operating Update
Phase 2b Study for oral PTH in osteoporosis to begin by mid-year 2019 Completed Part 2 of a Phase 2 PK/PD study in hypoparathyroidism patients. Data processing and statistical analysi.....»»
Karyopharm reports updated data from Phase 2b SADAL study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Theravance Biopharma reports new data from Phase 2 clinical study of TD-9855
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Mallinckrodt Presents Encouraging Data on Acthar Gel for RA
Mallinckrodt (MNK) reports encouraging results from a phase IV study on Acthar for RA at the EUL.....»»
CymaBay Down on Dismal Interim Data From Mid-Stage NASH Study
CymaBay (CBAY) plummets as a phase IIb study on lead candidate, seladelpar, fails to show meaningful reductions in liver fat. .....»»
CymaBay reports topline 12-week data from ongoing Phase 2b study of seladelpar
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Dr. Reddy"s Reports Positive Top-Line Data on Psoriasis Drug
Dr. Reddy's (RDY) reports positive top-line results from the phase IIb study on PPC-06 (formerly referred to as XP23829) in patients with moderate.....»»
Aptinyx reports top-line data from Phase 2 study of NYX-2925
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Cara Shares Up on Positive Phase III Data for Itchiness Drug
Cara (CARA) reports positive top-line data from phase III study of Korsuva injection in hemodialysis patients with moderate-to-severe chronic kidney disease-related pruritus. Want th.....»»
Myovant Sciences Provides Corporate Updates and Reports Financial Results for Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2019
-Announced positive Phase 3 results from LIBERTY 1 study evaluating relugolix combination therapy in women with uterine fibroids- -Data from four additional Phase 3 clinical studies ex.....»»
Theravance Biopharma reports data from Phase 1b study of JAK inhibitor TD-1473
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Rhythm Pharmaceuticals Reports First Quarter 2019 Financial Results
- Announced updated clinical data from Phase 2 basket study of setmelanotide in MC4R pathway heterozygous (HET) obesity, demonstrating consistent weight and hunger responses in patients with high-i.....»»
Alnylam (ALNY) Reports Phase III ENVISION Data on Givosiran
Alnylam (ALNY) reports complete positive results from the phase III ENVISION study of givosiran for the treatment of acute hepatic .....»»
Intercept falls after releasing "supportive data" from Phase 3 NASH study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»